Floatz logo

Abiraterone Acetate

Brain Tumor

Providence Health & ServicesPhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

41 Active assets in the Brain Tumor cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Essen Biotech
Phase 3BB
Irinotecan
NaviFUS Corporation
Phase 3BB
Clevidipine
NYU Langone Health
Phase 4BB
Hydralazine
NYU Langone Health
Phase 4BB
LABETALOL
NYU Langone Health
Phase 4BB

View all 50 →

Same molecule, other indications

Abiraterone Acetate is also rated in:

prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Metastatic Castration Resistant Prostate CancerDormant
BBB
Indicative ·
72 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →